Lack of reversal effect of EDTA treatment on cadmium induced renal dysfunction: A fourteen-year follow-up

BioMetals

Volumn 17, Issue 4, 2004, Pages 435-441

  Wu, Xunwei ^a   Su, Suhua ^b   Zhai, Rihong ^b   Chen, Kekuan ^b   Jin, Taiyi ^a   Huang, Bo ^a   Zhou, Yuanfen ^a   Ge, Xianmin ^b   Wei, Guoming ^b   Liao, Ruiqing ^b  

^a FUDAN UNIVERSITY   (China)

^b 530021 China   (China)

Author keywords

cadmium; ethylenediaminetetraacetic acid (EDTA); renal dysfunction; reversibility

Indexed keywords

BETA 2 MICROGLOBULIN; CADMIUM; CREATININE; EDETIC ACID;

ADULT; ARTICLE; CADMIUM POISONING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PROTEIN BLOOD LEVEL; URINALYSIS;

ADULT; AGED; BETA 2-MICROGLOBULIN; CADMIUM; EDETIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREVALENCE; TIME FACTORS;

EID: 3042764413     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BIOM.0000029440.23884.d6     Document Type: Article

References (29)

1. Andersen O. 1984 Chelation of cadmium. Environ Health Perspect 54, 249-266.
2. Bernard A, Roels H, Buchet JP, et al.: The Belgium experience. In: Nordberg GF, Herber RFM, Alessio L. (eds.) 1992 Cadmium in the Human Environment: Toxicity and Carcinogenicity. IARC Scientific publications. International Agency for Research on Cancer. Lyon, 118, 15-33.
3. Bo H, Wu XW, Jin TY. 2000 Dose-effect relation between cadmium exposure and renal dysfunction in workers occupationally exposed to cadmium. J Labour Med 17, 78-80 (in Chinese).
4. Cai S, Yue L, Jin T, Nordberg GF. 1998 Cadmium and renal dysfunction: Dose response in a population living in an area contaminated by irrigation water. WHO Bull 76, 153-159.
5. Elinder CG, Edling C, Lindberg E et al. 1985 β2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analysis. Am J Ind Med 8, 553-564.
6. Evrin PE, Peterson PA, Wide L et al. 1971 Radioimmunoassy of β2-microglobulin in human biological fluids. Scand. J. Clin. Lab. Invest 28, 439-143.
7. Friberg L, Elinder CG, Kjellström T et al. 1985 Cadmium and Health: A toxicological and Epidemiological Appraisal. Vol II, Boca Raton, Florida: CRC press, 1, 159.
8. Friberg L and Nystrom A. 1952 Aspects on the prognosis in chronic cadmium poisoning. Lakartidningen 49, 2629-2639 (in Swedish).
9. Friberg L, Nordberg GF, Vouk VB, (eds.) Handbook of Toxicology of Metals. Elsevier/NorthHolland, New York, 1979.
10. Hilmy AM, el-Domiaty NA, Daabees AY et al. 1986 The use of the chelating agent EDTA in the treatment of acute cadmium toxicity, tissue distribution and some blood parameters in the Egyptian toad Bufo regularis. Comp Biochem Physiol 85, 67-74.
11. Ishizaki M, Kido T, Honda R et al. 1989 Dose-response relationship between urinary cadmium and β2-microglobulin in a Japanese environmentally cadmium exposed population. Toxicol 58, 121-131.
12. Itawa K, Saito H, Moriyama M et al. 1993 Renal tubular function after reduction of environmental cadmium exposure: A ten-year follow-up. Archives of Environ Health 48, 157-163.
13. Jin T, Nordberg GF, Wu X et al. 1999 Urinary N-acetyl-β-D- glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res. A81, 167-173.
14. Kelley C, Sargent DE, Uno JK. 1999 Cadmium therapeutic agents. Curr Pharm Des 5, 229-240.
15. Kido T, Nogawa K. 1993 Dose-response relationship between total cadmium intake and β2-microglobulinuria using logistic regression analysis. Toxicol Let 69, 113-120.
16. Klaassen CD, Waalkes MP, Cantilena LR. 1984 Alteration of tissue disposition of cadmium by chelating agents. Environ Health Perpect 54, 233-242.
17. Klaassen CD, Ambdur and Doull Eds. Cassaret and Doulls' Toxicology: The basic Sciences of Poisons. Macmillan, 2001.
18. Kowal NE, Zirkes M. 1983 Urinary cadmium and b2-micoglobulin: normal values and concentration adjustment. J Toxicol Environ Health 11, 607-624.
19. Lauwerys R, Roels H, Regniers M et al. 1979 Significance of cadmium concentration in blood and in urine in workers exposed to cadmium. Environ Res 20, 375-391.
20. Lauwerys R. 1983 Industrial Chemical Exposure: Guidelines for Biological Monitoring. Davis, California, Biological Publications, 17-20
21. Nogawa K, Kido T, Shaikh YA. 1992 Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium. In: Nordberg, G, Herber, RFM and Alessio, L (eds.) Cadmium in the Human Environment: Toxicity and Carcinogenicity. IARC Scientific Publication, Lyon, 118, 311-318.
22. Roels H, Djubgang J, Buchet JP et al. 1982 Evolution of cadmium induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 8, 191-200.
23. Shitomi K, Saito H, Nakano A. 1981 Urinary β2-microglobulin for residents in an environmentally cadmium-polluted area. Studies of generational and sexual differences, and a comparison with the results of proximal renal tubular tests. Japan J Nephrol 23, 45-62.
24. Stewart M and Hughes E. 1981 Urinary β2 microglobulin in the biological monitoring of cadmium workers. Br J Ind Med 38, 170-174.
25. Tsuchiya K. 1976 Proteinuria of cadmium workers. J Occup Med 18, 463-466.
26. WHO/IPCS. 1992 Environmental Health Criteria Document 134 Cadmium. World Health Organisation, Geneva.
27. Wu X, Jin T. 2000 The review of study of reversibility of renal dysfunction caused by cadmium. Ind Hyg Occup Dis 26, 254-256 (in Chinese).
28. Wu X, Huang B, Jin T. 2000 Urinary N-acetyl-β-D-glucosaminidase as a diagnostic marker of occupational cadmium poisoning. Chinese J Ind Med 13, 193-195 (in Chinese).
29. Zhuo J, Hu WD, Ji SQ. 1989 Cancer mortality among cadmium production workers. Ind Hyg Occup Dis 15, 88-91 (in Chinese).